Health

781 bookmarks
Newest
Most Effective Back Pain Relief Feldenkrais Lesson
Most Effective Back Pain Relief Feldenkrais Lesson
Doron is introducing here his favorite go-to lesson as a remedy for back pain. While it’s not necessarily a “formula” for relieving back pain, Doron has taught this lesson to hundreds of people who have benefitted from it. For starters, it’s worth mentioning the best kept secret of “lying on the side in a fetal position” as a way of managing back/spinal pain (as opposed to lying supine or prone). The basic idea of the lesson is very simple - lie on your side, bend knees in front. Support your head comfortably, and start sliding your top long arm directly forward, hand resting on floor. The first constraint is: not bending the elbow! The movement comes from the rolling of your torso. Pay extra attention to the ribs under you and the ground forces that you are using to roll forward and back. Move very small. Gradually, notice the pelvis - can it stay quiet? The head - can it effortlessly move on its own, meaning - without the intention of moving it, simply as a consequence to the rolling of the upper thoracic. Please remember - if you’re in pain, this lesson is most effective when done extremely small, slow and gentle. enjoy :)
·youtube.com·
Most Effective Back Pain Relief Feldenkrais Lesson
Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image study - PubMed
Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image study - PubMed
The results of this study suggest that AOM can reduce mood episode relapse and may be clinically beneficial in the treatment of BD patients, potentially reducing issues associated with polypharmacy in some individuals.
·pubmed.ncbi.nlm.nih.gov·
Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image study - PubMed
Effects of Fish Oil and Dietary Antioxidant Supplementation on Bone Health of Growing Lambs - PubMed
Effects of Fish Oil and Dietary Antioxidant Supplementation on Bone Health of Growing Lambs - PubMed
The aim of the present study was to assess the effects of partial replacement of rapeseed oil (RO) with fish oil (FO) combined with dietary supplementation of various antioxidants on the characteristics of lamb femur. Thirty male lambs were assigned to five dietary treatments and fed isoproteinous a …
·pubmed.ncbi.nlm.nih.gov·
Effects of Fish Oil and Dietary Antioxidant Supplementation on Bone Health of Growing Lambs - PubMed
Selenium combined with vitamin E and vitamin C restores structural alterations of bones in heparin-induced osteoporosis - PubMed
Selenium combined with vitamin E and vitamin C restores structural alterations of bones in heparin-induced osteoporosis - PubMed
The aim of this study was to investigate the effect of heparin on osteoporosis initiation, and the effect of selenium plus vitamins E and C, and the sole combination of vitamins E and C on the progress of osteoporosis induced by heparin through histologic means. Adult female New Zealand white rabbit …
·pubmed.ncbi.nlm.nih.gov·
Selenium combined with vitamin E and vitamin C restores structural alterations of bones in heparin-induced osteoporosis - PubMed
Introducing the Mallows – True friends indeed - Wonderment Gardens
Introducing the Mallows – True friends indeed - Wonderment Gardens
The Mallows -Marshmallow (Althaea Officinalis), Common Mallow (Malva Neglecta), Globe Mallow (Sphaeralcea coccinea), and Hollyhock (Alcea rosea), all share similar properties and uses.
Dandelion
roots or the whole plant
soothing, cooling and alkalizing
combines well with Dandelion
relieve the pain
help break down urinary and gallstones
·wondermentgardens.com·
Introducing the Mallows – True friends indeed - Wonderment Gardens
Bromelian: the Pineapple Enzyme that Fights Multiple Diseases
Bromelian: the Pineapple Enzyme that Fights Multiple Diseases
Connective tissue injuries, such as ACL tears
Sprained ankles
Tendonitis
Allergies
Arthritis, joint pain and osteoarthritis
Digestive issues like heartburn or diarrhea
Cardiovascular disorders
Asthma
Autoimmune diseases
Cancer
Inflammatory bowel disease
Sinus infections, such as bronchitis and sinusitis
Surgical trauma and slow healing of skin wounds or burns
Poor absorption of drugs, especially antibiotics, and symptoms due to taking medications
Connective tissue injuries, such as ACL tears Sprained ankles Tendonitis Allergies Arthritis, joint pain and osteoarthritis Digestive issues like heartburn or diarrhea Cardiovascular disorders Asthma Autoimmune diseases Cancer Inflammatory bowel disease Sinus infections, such as bronchitis and sinusitis Surgical trauma and slow healing of skin wounds or burns Poor absorption of drugs, especially antibiotics, and symptoms due to taking medications
·draxe.com·
Bromelian: the Pineapple Enzyme that Fights Multiple Diseases
Dimethyl sulfoxide: Uses, Interactions, Mechanism of Action | DrugBank Online
Dimethyl sulfoxide: Uses, Interactions, Mechanism of Action | DrugBank Online
the cardiovascular protective effect of dimethyl sulfoxide in copper-deficient rats is thought to occur by an antioxidant mechanism
the cardiovascular protective effect of dimethyl sulfoxide in copper-deficient rats is thought to occur by an antioxidant mechanism
·go.drugbank.com·
Dimethyl sulfoxide: Uses, Interactions, Mechanism of Action | DrugBank Online
Biohack: DMSO for Transdermal Substance Delivery
Biohack: DMSO for Transdermal Substance Delivery
DMSO (dimethyl sulfoxide) was discovered in the mid-1800’s and has two fascinating properties for any biohackers toolbox. This substance is able push other chemicals through the skin directly…
·blog.adafruit.com·
Biohack: DMSO for Transdermal Substance Delivery
DMSO Is Not a Cure-All. But the FDA’s Panic Over It Birthed a Myth.
DMSO Is Not a Cure-All. But the FDA’s Panic Over It Birthed a Myth.
Imagine a drug so powerful, your government didn’t want you to have it. Now, add the claim that this drug is all natural (it’s not) and that people report it cured them of any ailment you can think of, and you have the recipe for a good old-fashioned conspiracy theory. An online survey of a nationally representative set of 1,351 American adults in 2013 revealed a shocking statistic: over a third agreed that their regulatory agency, the Food and Drug Administration (FDA), was deliberately preventing the public from getting natural cures for diseases like cancer because of pressure from drug companies. Another third said they neither agreed nor disagreed with that statement. The story of DMSO is a good illustration of why this belief is so widespread. This foul-smelling by-product of the wood-pulp industry has acquired over the decades a very broad health halo, which includes treating sprains, pains, strokes, and scars. But the main reason for this halo is what happened when the FDA, in the shadow of a worldwide tragedy, had to decide what to do with DMSO in the 1960s. Paper profits DMSO or dimethyl sulfoxide is a small molecule centred around a sulphur atom. Its isolation was first reported in 1867 by Russian chemist Alexander Zaytsev. Importantly, it is generated as a waste when wood fibres are broken down during the manufacture of paper. At the beginning of the 1960s, an Oregon-based paper goods manufacturer, the Crown Zellerbach Company, asked its staff chemist Robert Herschler if all of this DMSO that they had to get rid of could be used commercially in some fashion. Why throw something away when it could make you money? Herschler was approached by a professor of surgery at the local university named Stanley Jacob, who was interested in preserving biological material at very low temperatures for transplantation. A British team had noted that DMSO was a good antifreeze when storing blood cells, and Jacob wanted to get his hands on DMSO, so he went to the Crown Zellerbach Company. Following his meeting with Herschler, Jacob started to experiment with DMSO in the lab and this is where we find the origin story of DMSO as a medicine. As with most origin stories, it morphs in the telling. Apparently, one of Jacob’s assistants had burnt themselves in the lab… or had sprained their ankle. Jacob applied a bit of DMSO and voilà! It worked like magic. The thing about DMSO is that it has a tell-tale sign. It penetrates the skin very quickly and very efficiently, gets into your bloodstream, and reaches the lungs, where a bit of chemistry transforms it into dimethyl sulfide, which you exhale. It makes your breath smell of garlic, which like DMSO contains a lot of sulphur. This prompted Jacob and Herschler to think that DMSO—so deft at going through the skin and circulating throughout the body—might be a potent medicine. The story of the wood-pulp by-product wonder drug circulated as quickly as the drug itself does in the body, starting in the local media before quickly landing on the front page of The New York Times in 1963. The scientific press had been bypassed; instead, DMSO’s miraculous properties were cited in Newsweek and Life. Stock of the Crown Zellerbach Company temporarily shot up the day the NYT covered Oregon’s DMSO marvel: from $4.50 a share to an incredible $60.25. Pharmaceutical companies descended upon Crown, which had received an approval from the FDA to research the promising molecule. These companies wanted to put DMSO through its paces and eventually market it as a drug. Crown issued six research licenses in 1964 to some of the largest pharmaceutical companies at the time. After some testing, Schering was able to market DMSO in Germany in 1965; meanwhile, Merck, Squibb and Syntex filed new drug applications with the FDA in the US and crossed their fingers. This is where the seed for conspiracy ideation was planted. Safety is in the eye of the beholder The FDA did not always exist, and there was a time when medicines were not tested for their effectiveness or safety. Regulation often followed in the bloody footsteps of public health disasters. In 1961, in West Germany, pediatricians discovered that an outbreak of underdeveloped limbs in newborns—a congenital abnormality known as phocomelia—had been caused by thalidomide, a sedative often recommended to pregnant women for morning sickness and sleeping difficulties. Thalidomide famously had not been allowed entry into the U.S. market at the time, because Frances Kelsey, a reviewer for the FDA, had wanted to see more safety data. The rule was that a new drug was approved in the U.S. if an application was filed by its maker and the government took no action within two months. The government had to act to prevent a drug from being marketed, and drugs did not have to show that they were effective to be approved. Meanwhile, a senator from Tennessee, Estes Kefauver, wanted to tighten the screws around the drug industry to better protect consumers, and the worldwide thalidomide disaster lent credence to his proposal. In 1962, and for the very first time, a new drug in the United States now needed substantial evidence for its safety and effectiveness before being approved. And it is in this new regulatory landscape that DMSO enters the story. When Merck submitted its DMSO data to the FDA, it included a report from a veterinary at the University of Pennsylvania who had found that DMSO caused abnormal changes in the eyes of laboratory animals. Meanwhile, a woman in Ireland had used DMSO to heal a sprained wrist and had died three days later, possibly because she was allergic to the substance. This association was reported in The Wall Street Journal. The FDA—which was now much more cautious and was wielding a new decisional power over drugs—decided to deny the new drug application for DMSO. It also cancelled the paper manufacturing Crown Company’s power to hand out research contracts for the drug. In November 1965, it even sent telegrams to American doctors testing DMSO, to U.S. embassies, and to the World Health Organization: DMSO was possibly toxic to the eye and the FDA was recalling all unused doses of it. DMSO’s use in humans was effectively banned in America. (I recommend Phillip W. Davis’ paper on this whole story if you want the play-by-play.) This sudden fall of the hammer turned DMSO from a miracle drug into a persecuted drug, and it catalyzed the growth of an advocacy movement centred around Dr. Jacob, now the “father” of DMSO. The evidence for DMSO’s toxicity has since been mixed, with the drug receiving no robust, long-term studies of its safety. Testimonials for the drug’s effectiveness in treating an ever-longer list of illnesses replaced scientific evidence, and the FDA only ever approved its use for one disease: interstitial cystitis, a poorly understood bladder pain syndrome. DMSO’s popularity comes in bursts, with the last big one occurring at the beginning of the 1980s following a segment on the TV show 60 Minutes. Athletes swore by it, with a 1981 Sports Illustrated article declaring that “DMSO stinks up NFL locker rooms.” But does it even work? From that same article, the golden quote belongs to 22-year-old Alberto Salazar, one of America’s premier distance runners, who would go on to win a number of marathons before becoming embroiled in controversy. When asked about DMSO at the time, he said, “It is fickle stuff. Sometimes I get immediate relief and other times it doesn’t seem to work at all on a similar problem. It’s mysterious.” Smells fishy The scientific evidence for DMSO’s role in treating any disease is far from convincing. Research done in humans tends to come in the form of cohort studies, where people choose to use DMSO and are followed to see what happens to their ailment. There is no control group to see what would have happened without resorting to DMSO. In the few clinical trials done, placebo arms are rarely used. These lax methodologies invite a positive result that may not survive more rigorous testing. A systematic review of the evidence for DMSO in the treatment of osteoarthritis unearthed a measly four clinical trials. The trials using higher concentrations of the substance were negative, while the ones using lower concentrations were, mysteriously enough, positive, although the studies had a number of issues which makes them less than reliable. Even the evidence for DMSO being effective for interstitial cystitis is not great: a 2017 review of the evidence only lists three randomized clinical trials, and only one of them used a placebo arm. One of the strengths of a proper clinical trial is blinding: the person receiving the treatment and the person administering it should be blind to whether they are dealing with the real treatment or a placebo. This helps remove psychological factors that might influence the outcome, such as patients reporting feeling better simply because they knew they were receiving a drug. But with DMSO’s “death breath,” blinding is challenging. I have worked with DMSO in the laboratory. Its smell was often described as fish-like and you could tell when someone had opened up a small bottle of the stuff at the other end of the lab. I found one trial where the placebo was a very low dose of DMSO, in order to produce a similar smell. Thus, the blinding of almost every trial of DMSO should be questioned. DMSO is a great solvent, and it can be used as an effective “vehicle” to transport active drugs through the skin. When a team of researchers were looking for better treatments for knee osteoarthritis, they set their sights on diclofenac, which you can now buy at the drugstore under the name Voltaren. But they were clever. They tested diclofenac in a DMSO vehicle to facilitate its penetration through the skin… but they also tested DMSO on its own, as well as a placebo. The whole study lasted 12 weeks. And wouldn’t you know it, there was no difference in self-reported pain, physical function or overall he
·mcgill.ca·
DMSO Is Not a Cure-All. But the FDA’s Panic Over It Birthed a Myth.
Adverse reactions of dimethyl sulfoxide in humans: a systematic review
Adverse reactions of dimethyl sulfoxide in humans: a systematic review
Background: Dimethyl sulfoxide (DMSO) has been used for medical treatment and as a pharmacological agent in humans since the 1960s. Today, DMSO is used mostly for cryopreservation of stem cells, treatment of interstitial cystitis, and as a penetrating ...
·ncbi.nlm.nih.gov·
Adverse reactions of dimethyl sulfoxide in humans: a systematic review
The Best Men’s Boxer Briefs
The Best Men’s Boxer Briefs
These five boxer briefs are the most comfy, supportive, and good-looking we could find, and they start at less than four bucks a pair.
·nytimes.com·
The Best Men’s Boxer Briefs
Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women - PubMed
Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women - PubMed
The combination of low-dose trospium and solifenacin provides good clinical and urodynamic effects in elderly patients with moderate symptoms of OAB. Combination of these drugs in standard doses for such patients is excessive.
·pubmed.ncbi.nlm.nih.gov·
Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women - PubMed
Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia - PubMed
Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia - PubMed
This research is aimed to study the possibility of management of severe symptoms of overactive bladder (OAB) with solifenacin and trospium in patients who receive treatment with tamsulosin due to benign prostatic hyperplasia (BPH). The 338 men more than 50 years old (average age 58.4 years) diagnose …
·pubmed.ncbi.nlm.nih.gov·
Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia - PubMed